Clinical Trials Browser

Has results × becatecarin × Thoracic × Clear all

NCT00084487 2014-05-23

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Phase 2 Terminated

21 enrolled 12 charts

Small Cell Lung Carcinoma